Outcomes of Restrictive and Hypertrophic Cardiomyopathies After LVAD: An INTERMACS Analysis
Authors:
- 1 December 2017
- journal article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 23 (12) , 859-867
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal diseaseThe Journal of Heart and Lung Transplantation, 2015
- Centrifugal Continuous-Flow Left Ventricular Assist Device in Patients With Hypertrophic CardiomyopathyASAIO Journal, 2013
- Left Ventricular Assist Device Implantation in a Patient Who had Previously Undergone Apical Myectomy for Hypertrophic CardiomyopathyJournal of Cardiac Surgery, 2012
- Left Ventricular Assist Device Therapy in Patients With Restrictive and Hypertrophic CardiomyopathyCirculation: Heart Failure, 2011
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceNew England Journal of Medicine, 2009
- INTERMACS Database for Durable Devices for Circulatory Support: First Annual ReportThe Journal of Heart and Lung Transplantation, 2008
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationNew England Journal of Medicine, 2007
- Dilated-Hypokinetic Evolution of Hypertrophic CardiomyopathyJACC, 2005
- Clinical Profile and Outcome of Idiopathic Restrictive CardiomyopathyCirculation, 2000
- Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of CardiomyopathiesCirculation, 1996